MCID: CLL002
MIFTS: 43

Collecting Duct Carcinoma

Categories: Rare diseases, Nephrological diseases, Cancer diseases

Aliases & Classifications for Collecting Duct Carcinoma

MalaCards integrated aliases for Collecting Duct Carcinoma:

Name: Collecting Duct Carcinoma 12 53 59 15
Renal Medullary Carcinoma 12 53 59
Collecting Duct Carcinoma of the Kidney 53 73
Kidney Medullary Carcinoma 53 73
Bellini Duct Carcinoma 53 59
Bellini Carcinoma 53 59
Bdc 53 59
Cdc 53 59
Renal Carcinoma, Collecting Duct Type 12
Carcinoma of Renal Collecting Duct 12
Renal Collecting Duct Carcinoma 53
Bellini’s Duct Carcinoma 53

Characteristics:

Orphanet epidemiological data:

59
collecting duct carcinoma
Inheritance: Not applicable; Age of onset: Adult;

Classifications:

Orphanet: 59  
Rare renal diseases


External Ids:

Disease Ontology 12 DOID:4464
MeSH 44 D002292
NCIt 50 C6194
SNOMED-CT 68 128669006
ICD10 via Orphanet 34 C64
MESH via Orphanet 45 D002292
UMLS via Orphanet 74 C1266044

Summaries for Collecting Duct Carcinoma

NIH Rare Diseases : 53 Collecting duct carcinoma (CDC) is a rare and aggressive form of kidney cancer that begins in the collecting duct of the kidney. Many people with CDC have no signs or symptoms until the cancer is at an advanced stage. Symptoms may include flank pain, unexplained weight loss, or blood in the urine. Although it can affect people of all ages, CDC tends to occur in younger patients. The exact cause of CDC is unknown. It usually occurs in people with no family history of the condition. Treatment options for CDC may include surgery and/or chemotherapy.

MalaCards based summary : Collecting Duct Carcinoma, also known as renal medullary carcinoma, is related to renal cell carcinoma, nonpapillary and spindle cell carcinoma, and has symptoms including flank pain An important gene associated with Collecting Duct Carcinoma is XIST (X Inactive Specific Transcript
In cell linecreated from the tissue of both a male patient and a female patient with collecting duct carcinoma of the kidney,the XIST gene,along with several other chromosome X genes,was found to have an increase in copy number. The results suggest that TOP1 might be one of the molecular targets in AP8 CDC cells. Thus,these novel CDC cell linewill be useful for discovering therapeutic targets and developing effective anticancer drugs against CDC.
Dysfunction Pattern: Regulation [up-regulated]). The drugs Bexxar and Unituxin have been mentioned in the context of this disorder. Affiliated tissues include kidney, b cells and bone.

Disease Ontology : 12 Collecting duct carcinoma is a renal cell carcinoma described as a rare and aggressive type of renal cell carcinoma. The cancerous cells form irregular tubes inside the tumor. Collecting duct carcinoma is more common among young people and unfortunately is diagnosed in most cases when the cancer has metastasized (spread inside the body).

Wikipedia : 76 Collecting duct carcinoma (CDC) (also known as Bellini duct carcinoma), is a type of kidney cancer that... more...

Related Diseases for Collecting Duct Carcinoma

Diseases related to Collecting Duct Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 167)
# Related Disease Score Top Affiliating Genes
1 renal cell carcinoma, nonpapillary 31.0 AMACR KRT7 MME PAX8 SETD2
2 spindle cell carcinoma 29.9 AMACR KRT7
3 oncocytoma 29.4 AMACR KRT7 MME
4 chromophobe renal cell carcinoma 29.2 KRT7 MME
5 clear cell renal cell carcinoma 29.1 KRT7 MME PBRM1 SETD2
6 renal cell carcinoma, papillary, 1 28.9 AMACR KRT7 MME PAX8
7 brachydactyly, type c 11.2
8 bazex syndrome 11.2
9 porphyria, acute hepatic 11.1
10 renal cell carcinoma, xp11-associated 11.0
11 angioedema, hereditary, type i 10.9
12 platelet membrane fluidity 10.9
13 chagas disease 10.9
14 diabetes insipidus, neurohypophyseal 10.7
15 carney complex, type 1 10.7
16 pancreatitis, hereditary 10.7
17 citrullinemia, classic 10.7
18 conotruncal heart malformations 10.7
19 glycogen storage disease ii 10.7
20 nicolaides-baraitser syndrome 10.7
21 congenital disorder of glycosylation, type ib 10.7
22 duane-radial ray syndrome 10.7
23 traumatic brain injury 10.7
24 salmonellosis 10.7
25 tetanus 10.7
26 hantavirus pulmonary syndrome 10.7
27 folliculitis 10.7
28 toxocariasis 10.7
29 acute flaccid myelitis 10.7
30 congenital rubella 10.7
31 congenital zika syndrome 10.7
32 neurosyphilis 10.7
33 nodding syndrome 10.7
34 zika virus infection 10.7
35 nephrogenic adenoma of urinary bladder 10.5 KRT7 PAX8
36 bladder benign neoplasm 10.5 KRT7 PAX8
37 vulvar sarcoma 10.5 KRT7 SMARCB1
38 endosalpingiosis 10.5 KRT7 PAX8
39 renal pelvis adenocarcinoma 10.5 KRT7 PAX8
40 endocervical carcinoma 10.5 KRT7 PAX8
41 renal pelvis carcinoma 10.4 KRT7 PAX8
42 epithelial-myoepithelial carcinoma 10.4 KRT7 SMARCB1
43 endocervical adenocarcinoma 10.4 KRT7 PAX8
44 urethra adenocarcinoma 10.4 AMACR PAX8
45 renal adenoma 10.4 AMACR KRT7
46 urethra clear cell adenocarcinoma 10.4 AMACR PAX8
47 epithelial predominant wilms' tumor 10.4 AMACR KRT7
48 ovarian mucinous adenocarcinoma 10.4 AMACR KRT7
49 spindle cell synovial sarcoma 10.4 KRT7 SMARCB1
50 clear cell hidradenoma 10.4 MME PAX8

Graphical network of the top 20 diseases related to Collecting Duct Carcinoma:



Diseases related to Collecting Duct Carcinoma

Symptoms & Phenotypes for Collecting Duct Carcinoma

UMLS symptoms related to Collecting Duct Carcinoma:


flank pain

Drugs & Therapeutics for Collecting Duct Carcinoma

FDA approved drugs:

# Drug Name Active Ingredient(s) 18 Company Approval Date
1
Bexxar 18 49 TOSITUMOMAB; IODINE I 131 TOSITUMOMAB Corixa June 2003
2
Unituxin 18 49 DINUTUXIMAB United Therapeutics March 2015

Drugs for Collecting Duct Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 30)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Sunitinib Approved, Investigational Phase 2 341031-54-7, 557795-19-4 5329102
2
Gemcitabine Approved Phase 2 95058-81-4 60750
3
Bevacizumab Approved, Investigational Phase 2 216974-75-3
4
Cisplatin Approved Phase 2 15663-27-1 84093 441203 2767
5
Sorafenib Approved, Investigational Phase 2 284461-73-0 216239 406563
6
Miconazole Approved, Investigational, Vet_approved Phase 2 22916-47-8 4189
7
Everolimus Approved Phase 2 159351-69-6 6442177
8
Sirolimus Approved, Investigational Phase 2 53123-88-9 5284616 6436030 46835353
9
Nicotinamide Approved, Investigational, Nutraceutical Phase 2 98-92-0 936
10
Niacin Approved, Investigational, Nutraceutical Phase 2 59-67-6 938
11
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
12 Angiogenesis Inhibitors Phase 2
13 Angiogenesis Modulating Agents Phase 2
14 Immunosuppressive Agents Phase 2
15 Anti-Infective Agents Phase 2
16 Antimetabolites Phase 2
17 Antiviral Agents Phase 2
18 Antimetabolites, Antineoplastic Phase 2
19 Micronutrients Phase 2
20 Nicotinic Acids Phase 2
21 Trace Elements Phase 2
22 Anti-Bacterial Agents Phase 2
23 Vitamin B Complex Phase 2
24 Antibiotics, Antitubercular Phase 2
25 Vitamins Phase 2
26 Antifungal Agents Phase 2
27 Protein Kinase Inhibitors Phase 2
28 Folate Nutraceutical Phase 2
29 Vitamin B3 Nutraceutical Phase 2
30 Vitamin B9 Nutraceutical Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma Unknown status NCT01219751 Phase 2 Sunitinib
2 Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer Completed NCT00465179 Phase 2 Sunitinib Malate
3 Study of Gemcitabine+Platinium Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (GETUG-AFU 24) Recruiting NCT02363751 Phase 2 Bevacizumab
4 caBozantinib in cOllectiNg ductS Renal Cell cArcInoma Recruiting NCT03354884 Phase 2 Cabometyx
5 Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma Active, not recruiting NCT01762150 Phase 2 Sorafenib;Gemcitabine;Cisplatin
6 Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Active, not recruiting NCT01767636 Phase 2 Pazopanib Hydrochloride
7 Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma Active, not recruiting NCT01185366 Phase 2 Everolimus;Sunitinib

Search NIH Clinical Center for Collecting Duct Carcinoma

Genetic Tests for Collecting Duct Carcinoma

Anatomical Context for Collecting Duct Carcinoma

MalaCards organs/tissues related to Collecting Duct Carcinoma:

41
Kidney, B Cells, Bone, Neutrophil, Thyroid, Pancreas, Salivary Gland

Publications for Collecting Duct Carcinoma

Articles related to Collecting Duct Carcinoma:

(show top 50) (show all 134)
# Title Authors Year
1
Prognostic significance of neutrophil-to-lymphocyte ratio in collecting duct carcinoma. ( 29846639 )
2018
2
Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study. ( 29933095 )
2018
3
Management of Metastatic Collecting Duct Carcinoma: An Encouraging Result in a Patient Treated With Cabozantinib. ( 29656939 )
2018
4
Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma. ( 29309300 )
2018
5
BK virus-associated collecting duct carcinoma of the renal allograft in a kidney-pancreas allograft recipient. ( 29599935 )
2018
6
Clinicopathologic and Molecular Pathology of Collecting Duct Carcinoma and Related Renal Cell Carcinomas. ( 28181950 )
2017
7
A Case of Metastatic Collecting Duct Carcinoma Whose Massive Skull Bone Metastasis was Prominently Reossified by Gemcitabine Plus Cisplatin Chemotherapy Combined with Zoledronic Acid. ( 28932690 )
2017
8
Sarcomatoid Renal Cell Carcinoma and Collecting Duct Carcinoma: Discrimination From Common Renal Cell Carcinoma Subtypes and Benign RCC Mimics on Multiphasic MDCT. ( 28528853 )
2017
9
Response to nivolumab in metastatic collecting duct carcinoma expressing PD-L1: A case report. ( 29285361 )
2017
10
Collecting Duct Carcinoma of the Native Kidney in a Renal Transplant Recipient. ( 29062581 )
2017
11
Collecting duct carcinoma of the kidney: Disease characteristics and treatment outcomes from the National Cancer Database. ( 28495554 )
2017
12
Anti-programmed Death Receptor 1 Blockade Induces Clinical Response in a Patient With Metastatic Collecting Duct Carcinoma. ( 27021586 )
2016
13
Collecting Duct Carcinoma With Cardiac Metastases: A Case Report &A Literature Review. ( 26977410 )
2016
14
A renal adenocarcinoma in a corn snake (Pantherophis guttatus) resembling human collecting duct carcinoma. ( 27493139 )
2016
15
Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation. ( 27144525 )
2016
16
Enhanced MRI and 18F-FDG PET/CT Findings of Preoperative Primary Renal Collecting Duct Carcinoma. ( 27775947 )
2016
17
Targeted Therapy in Collecting Duct Carcinoma of the Kidney: A Case Report and Literature Review. ( 26684811 )
2016
18
Retraction Note: Collecting duct carcinoma of the kidney: a clinicopathological study of five cases. ( 25884188 )
2015
19
Collecting duct carcinoma of the kidney: A case report. ( 26137167 )
2015
20
Papillary renal cell carcinoma and collecting duct carcinoma combination. A case report and review of synchronous renal cell carcinoma subtypes in the same kidney. ( 26170866 )
2015
21
Comparative study of CT appearances in mucinous tubular and spindle cell carcinoma and collecting duct carcinoma of the kidney. ( 26435393 )
2015
22
Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling. ( 26149668 )
2015
23
Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity. ( 24805860 )
2014
24
Clinical features and treatment of collecting duct carcinoma of the kidney from the korean cancer study group genitourinary and gynecology cancer committee. ( 24851105 )
2014
25
Collision tumor of the kidney composed of clear cell carcinoma and collecting duct carcinoma: report of a case with unusual morphology and clinical follow-up. ( 24589208 )
2014
26
Treatment of collecting duct carcinoma: current status and future perspectives. ( 24511050 )
2014
27
A collecting duct carcinoma producing carcinoembryonic antigen and Ca-125 in a 29-year-old woman. ( 24531923 )
2014
28
Collecting duct carcinoma of the kidney. A contribution of 4 new cases. ( 25306992 )
2014
29
Composite chromophobe renal cell carcinoma with sarcomatoid differentiation containing osteosarcoma, chondrosarcoma, squamous metaplasia and associated collecting duct carcinoma: a case report. ( 25291862 )
2014
30
Collecting duct carcinoma of the kidney: Imaging observations of a rare tumor. ( 24396480 )
2014
31
Salivary gland-type renal carcinoma, a subset of collecting duct carcinoma: case report and meta-analysis of the entity. ( 23339365 )
2013
32
The MSCT and MRI findings of collecting duct carcinoma. ( 23726725 )
2013
33
Management of renal collecting duct carcinoma: a systematic review and the McMaster experience. ( 23737692 )
2013
34
Active targeted therapy for metastatic collecting duct carcinoma of the kidney: a case report and review of the literature. ( 23686671 )
2013
35
Renal collecting duct carcinoma: report of a case with unusual imaging findings regarding renal function. ( 23771391 )
2013
36
Collecting duct carcinoma: a rare malignancy. ( 23575082 )
2013
37
The multislice CT findings of renal carcinoma associated with XP11.2 translocation/TFE gene fusion and collecting duct carcinoma. ( 23446748 )
2013
38
Collecting duct carcinoma of the kidney: a clinicopathological study of five cases. ( 23773436 )
2013
39
Triple combination of bevacizumab, gemcitabine and platinum salt in metastatic collecting duct carcinoma. ( 24190963 )
2013
40
Renal collecting duct carcinoma with extensive coagulative necrosis mimicking anemic infarct: report of a case and the literature review. ( 23866935 )
2013
41
Distal ureteral seeding metastasis of collecting duct carcinoma manifesting as deep vein thrombosis. ( 22513238 )
2012
42
Tubulocystic renal carcinoma (low grade collecting duct carcinoma). ( 23154610 )
2012
43
Collecting duct carcinoma presenting uncommon metastatic features. ( 23235769 )
2012
44
A case report of collecting duct carcinoma of the kidney coexistent with giant adrenal myelolipoma. ( 22511446 )
2012
45
HER2 blockade in metastatic collecting duct carcinoma (CDC) of the kidney: a case report. ( 23207624 )
2012
46
Thyroid transcription factor 1 expression in a case of renal collecting duct carcinoma. ( 22703591 )
2012
47
Collecting duct carcinoma: a rare renal tumor. ( 22805397 )
2012
48
Retraction: Metastatic collecting duct carcinoma of the kidney treated with Sunitinib. ( 22024397 )
2011
49
Metastatic collecting duct carcinoma of the kidney treated with sunitinib. ( 21752265 )
2011
50
Immunohistochemical analysis of SMARCB1/INI-1 expression in collecting duct carcinoma. ( 21705046 )
2011

Variations for Collecting Duct Carcinoma

Cosmic variations for Collecting Duct Carcinoma:

9
(show top 50) (show all 260)
# Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA GRCh38 Location Conf
1 COSM10659 TP53 kidney,NS,carcinoma,collecting duct carcinoma c.817C>T p.R273C 17:7673803-7673803 35
2 COSM3355991 kidney,NS,carcinoma,collecting duct carcinoma c.817C>T p.R273C 17:7673803-7673803 35
3 COSM99933 kidney,NS,carcinoma,collecting duct carcinoma c.817C>T p.R273C 17:7673803-7673803 35
4 COSM1645518 kidney,NS,carcinoma,collecting duct carcinoma c.817C>T p.R273C 17:7673803-7673803 35
5 COSM6941466 XIAP kidney,NS,carcinoma,renal cell carcinoma c.563G>C p.G188A 23:123886225-123886225 30
6 COSM14312 VHL kidney,NS,carcinoma,renal cell carcinoma c.353T>C p.L118P 3:10146526-10146526 30
7 COSM14380 VHL kidney,NS,carcinoma,renal cell carcinoma c.548C>A p.S183* 3:10149871-10149871 30
8 COSM18350 VHL kidney,NS,carcinoma,renal cell carcinoma c.256C>T p.P86S 3:10142103-10142103 30
9 COSM17957 VHL kidney,NS,carcinoma,renal cell carcinoma c.292T>G p.Y98D 3:10142139-10142139 30
10 COSM14382 VHL kidney,NS,carcinoma,renal cell carcinoma c.245G>C p.R82P 3:10142092-10142092 30
11 COSM14305 VHL kidney,NS,carcinoma,renal cell carcinoma c.266T>A p.L89H 3:10142113-10142113 30
12 COSM25676 VHL kidney,NS,carcinoma,renal cell c.485G>T p.C162F 3:10149808-10149808 30
13 COSM17875 VHL kidney,NS,carcinoma,renal cell carcinoma c.234T>G p.N78K 3:10142081-10142081 30
14 COSM17983 VHL kidney,NS,carcinoma,renal cell carcinoma c.500G>A p.R167Q 3:10149823-10149823 30
15 COSM18097 VHL kidney,NS,carcinoma,renal cell carcinoma c.482G>A p.R161Q 3:10149805-10149805 30
16 COSM14425 VHL kidney,NS,carcinoma,renal cell carcinoma c.341-2A>T p.? 3:10146512-10146512 30
17 COSM17872 VHL kidney,NS,carcinoma,renal cell carcinoma c.217C>T p.Q73* 3:10142064-10142064 30
18 COSM27269 UMPS kidney,NS,carcinoma,renal cell c.528G>A p.L176L 3:124737785-124737785 30
19 COSM6957851 TSC2 kidney,NS,carcinoma,renal cell carcinoma c.541G>A p.V181M 16:2055461-2055461 30
20 COSM6942356 TSC1 kidney,NS,carcinoma,renal cell carcinoma c.2287C>T p.Q763* 9:132902709-132902709 30
21 COSM6963117 TSC1 kidney,NS,carcinoma,renal cell carcinoma c.1001C>A p.S334* 9:132911481-132911481 30
22 COSM29770 TSC1 kidney,NS,carcinoma,renal cell carcinoma c.508+1G>T p.? 9:132923347-132923347 30
23 COSM30474 TRIO kidney,NS,carcinoma,renal cell c.9008A>G p.N3003S 5:14508136-14508136 30
24 COSM10656 TP53 kidney,NS,carcinoma,renal cell carcinoma c.742C>T p.R248W 17:7674221-7674221 30
25 COSM45243 TP53 kidney,NS,carcinoma,renal cell carcinoma c.374C>G p.T125R 17:7675995-7675995 30
26 COSM10647 TP53 kidney,NS,carcinoma,renal cell carcinoma c.404G>T p.C135F 17:7675208-7675208 30
27 COSM44310 TP53 kidney,NS,carcinoma,renal cell carcinoma c.738G>A p.M246I 17:7674225-7674225 30
28 COSM6922197 TP53 kidney,NS,carcinoma,renal cell carcinoma c.97-2A>C p.? 17:7676274-7676274 30
29 COSM45135 TP53 kidney,NS,carcinoma,renal cell carcinoma c.673-1G>T p.? 17:7674291-7674291 30
30 COSM6929752 TBX3 kidney,NS,carcinoma,renal cell carcinoma c.510G>T p.W170C 12:114681026-114681026 30
31 COSM6979493 STAG2 kidney,NS,carcinoma,renal cell carcinoma c.2096+1G>A p.? 23:124065947-124065947 30
32 COSM6975582 STAG2 kidney,NS,carcinoma,renal cell carcinoma c.1348A>T p.R450* 23:124057909-124057909 30
33 COSM6023628 STAG2 kidney,NS,carcinoma,renal cell carcinoma c.2860C>T p.R954C 23:124081464-124081464 30
34 COSM6963119 SPOP kidney,NS,carcinoma,renal cell carcinoma c.265T>G p.L89V 17:49619321-49619321 30
35 COSM6964939 SMARCB1 kidney,NS,carcinoma,renal cell carcinoma c.987-2A>T p.? 22:23833570-23833570 30
36 COSM989 SMARCB1 kidney,NS,carcinoma,renal cell carcinoma c.1130G>A p.R377H 22:23834152-23834152 30
37 COSM1266238 SMARCA4 kidney,NS,carcinoma,renal cell carcinoma c.3575G>A p.R1192H 19:11033318-11033318 30
38 COSM6947611 SETD2 kidney,NS,carcinoma,renal cell carcinoma c.863C>A p.S288* 3:47122264-47122264 30
39 COSM6975580 SETD2 kidney,NS,carcinoma,renal cell carcinoma c.4736C>G p.S1579* 3:47062211-47062211 30
40 COSM4118007 SETD2 kidney,NS,carcinoma,renal cell carcinoma c.3266G>A p.R1089Q 3:47106061-47106061 30
41 COSM4794860 SETD2 kidney,NS,carcinoma,renal cell carcinoma c.5922+1G>A p.? 3:47019759-47019759 30
42 COSM26594 RNF144A kidney,NS,carcinoma,renal cell c.410C>T p.A137V 2:7020581-7020581 30
43 COSM26987 RGS7 kidney,NS,carcinoma,renal cell c.169T>C p.F57L 1:241098672-241098672 30
44 COSM6925125 RBM10 kidney,NS,carcinoma,renal cell carcinoma c.179C>A p.S60* 23:47169476-47169476 30
45 COSM6922201 RBM10 kidney,NS,carcinoma,renal cell carcinoma c.299G>C p.G100A 23:47171125-47171125 30
46 COSM26614 RABGAP1 kidney,NS,carcinoma,renal cell c.1533T>A p.H511Q 9:123020414-123020414 30
47 COSM30530 PTPN22 kidney,NS,carcinoma,renal cell c.209G>C p.R70P 1:113859066-113859066 30
48 COSM6947629 PTCH1 kidney,NS,carcinoma,renal cell carcinoma c.3616C>T p.R1206C 9:95449257-95449257 30
49 COSM6927541 PRKN kidney,NS,carcinoma,renal cell carcinoma c.629T>G p.F210C 6:161973407-161973407 30
50 COSM6913448 POLE kidney,NS,carcinoma,renal cell carcinoma c.4735C>T p.R1579C 12:132642723-132642723 30

Expression for Collecting Duct Carcinoma

Search GEO for disease gene expression data for Collecting Duct Carcinoma.

Pathways for Collecting Duct Carcinoma

GO Terms for Collecting Duct Carcinoma

Biological processes related to Collecting Duct Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 chromatin organization GO:0006325 9.33 PBRM1 SETD2 SMARCB1
2 ATP-dependent chromatin remodeling GO:0043044 8.96 PBRM1 SMARCB1
3 nucleosome disassembly GO:0006337 8.62 PBRM1 SMARCB1

Sources for Collecting Duct Carcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....